These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 39153983)

  • 1. Evaluating trophinin associated protein as a biomarker of prognosis and therapy response in renal cell carcinoma.
    Tan Q; Kong P; Chen G; Cai Y; Liu K; Chen C; Mo H; Huang Y; Lu J; Wu Y
    BMC Cancer; 2024 Aug; 24(1):1021. PubMed ID: 39153983
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gankyrin is a novel biomarker for disease progression and prognosis of patients with renal cell carcinoma.
    Wang C; Li Y; Chu CM; Zhang XM; Ma J; Huang H; Wang YN; Hong TY; Zhang J; Pan XW; Zheng JC; Jiang N; Hu CY; Ma X; Sun YH; Cui XG
    EBioMedicine; 2019 Jan; 39():255-264. PubMed ID: 30558998
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TROAP Promotes the Proliferation, Migration, and Metastasis of Kidney Renal Clear Cell Carcinoma with the Help of STAT3.
    Wang J; Wan H; Mi Y; Wu S; Li J; Zhu L
    Int J Mol Sci; 2023 Jun; 24(11):. PubMed ID: 37298609
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pan-cancer analysis of trophinin-associated protein with potential implications in clinical significance, prognosis, and tumor microenvironment in human cancers.
    Li Z; Pu Z; Yang Z; Zhu Y; Deng Y; Li N; Peng F
    Front Oncol; 2022; 12():971618. PubMed ID: 36419876
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fc receptor-like A promotes malignant behavior in renal cell carcinoma and correlates with tumor immune infiltration.
    Liu JP; Jiang YF; Liu JW; Tian CJ; Lin YZ; Yang YZ; Zhang ZK; Fang YL; Huang B; Lin H
    Cancer Med; 2024 Aug; 13(15):e70072. PubMed ID: 39108036
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MiR-532-3p suppresses cell viability, migration and invasion of clear cell renal cell carcinoma through targeting TROAP.
    Gao B; Wang L; Zhang Y; Zhang N; Han M; Liu H; Sun D; Liu Y
    Cell Cycle; 2021 Aug; 20(16):1578-1588. PubMed ID: 34287099
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Integrated Molecular Characterization of Fumarate Hydratase-deficient Renal Cell Carcinoma.
    Sun G; Zhang X; Liang J; Pan X; Zhu S; Liu Z; Armstrong CM; Chen J; Lin W; Liao B; Lin T; Huang R; Zhang M; Zheng L; Yin X; Nie L; Shen P; Zhao J; Zhang H; Dai J; Shen Y; Li Z; Liu J; Chen J; Liu J; Wang Z; Zhu X; Ni Y; Qin D; Yang L; Chen Y; Wei Q; Li X; Zhou Q; Huang H; Yao J; Chen N; Zeng H
    Clin Cancer Res; 2021 Mar; 27(6):1734-1743. PubMed ID: 33414138
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification and validation of novel prognostic markers in Renal Cell Carcinoma.
    Rabjerg M
    Dan Med J; 2017 Oct; 64(10):. PubMed ID: 28975890
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A pan-kidney cancer study identifies subtype specific perturbations on pathways with potential drivers in renal cell carcinoma.
    Zhan X; Liu Y; Yu CY; Wang TF; Zhang J; Ni D; Huang K
    BMC Med Genomics; 2020 Dec; 13(Suppl 11):190. PubMed ID: 33371886
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The JAK-STAT signaling-related signature serves as a prognostic and predictive biomarker for renal cell carcinoma immunotherapy.
    Chan S; Liu Z; Chen Y; Chen S; Liang Y; Yang Z; Zhang Z; Li M; Zhang X; Liu X
    Gene; 2024 Nov; 927():148719. PubMed ID: 38917875
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High Trophinin-Associated Protein Expression Is an Independent Predictor of Poor Survival in Liver Cancer.
    Jiao Y; Li Y; Lu Z; Liu Y
    Dig Dis Sci; 2019 Jan; 64(1):137-143. PubMed ID: 30284652
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Upregulation of Trophinin-Associated Protein (TROAP) Predicts a Poor Prognosis in Hepatocellular Carcinoma.
    Hu H; Xu L; Chen Y; Luo SJ; Wu YZ; Xu SH; Liu MT; Lin F; Mei Y; Yang Q; Qiang YY; Lin YW; Deng YJ; Lin T; Sha YQ; Huang BJ; Zhang SJ
    J Cancer; 2019; 10(4):957-967. PubMed ID: 30854102
    [No Abstract]   [Full Text] [Related]  

  • 13. Bioinformatic identification of renal cell carcinoma microenvironment-associated biomarkers with therapeutic and prognostic value.
    Zeng Q; Zhang W; Li X; Lai J; Li Z
    Life Sci; 2020 Feb; 243():117273. PubMed ID: 31926244
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TFE3 Xp11.2 Translocation Renal Cell Carcinoma Mouse Model Reveals Novel Therapeutic Targets and Identifies GPNMB as a Diagnostic Marker for Human Disease.
    Baba M; Furuya M; Motoshima T; Lang M; Funasaki S; Ma W; Sun HW; Hasumi H; Huang Y; Kato I; Kadomatsu T; Satou Y; Morris N; Karim BO; Ileva L; Kalen JD; Wilan Krisna LA; Hasumi Y; Sugiyama A; Kurahashi R; Nishimoto K; Oyama M; Nagashima Y; Kuroda N; Araki K; Eto M; Yao M; Kamba T; Suda T; Oike Y; Schmidt LS; Linehan WM
    Mol Cancer Res; 2019 Aug; 17(8):1613-1626. PubMed ID: 31043488
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    Gong X; Liu Y; Zhang Q; Liang K; Wei J; Du H
    Int J Mol Sci; 2024 Jun; 25(12):. PubMed ID: 38928412
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    Lin TC
    Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32326089
    [TBL] [Abstract][Full Text] [Related]  

  • 17. miR-129-3p, as a diagnostic and prognostic biomarker for renal cell carcinoma, attenuates cell migration and invasion via downregulating multiple metastasis-related genes.
    Chen X; Ruan A; Wang X; Han W; Wang R; Lou N; Ruan H; Qiu B; Yang H; Zhang X
    J Cancer Res Clin Oncol; 2014 Aug; 140(8):1295-304. PubMed ID: 24802708
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A systematic search strategy identifies cubilin as independent prognostic marker for renal cell carcinoma.
    Gremel G; Djureinovic D; Niinivirta M; Laird A; Ljungqvist O; Johannesson H; Bergman J; Edqvist PH; Navani S; Khan N; Patil T; Sivertsson Å; Uhlén M; Harrison DJ; Ullenhag GJ; Stewart GD; Pontén F
    BMC Cancer; 2017 Jan; 17(1):9. PubMed ID: 28052770
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic implications of Aquaporin 9 expression in clear cell renal cell carcinoma.
    Xu WH; Shi SN; Xu Y; Wang J; Wang HK; Cao DL; Shi GH; Qu YY; Zhang HL; Ye DW
    J Transl Med; 2019 Nov; 17(1):363. PubMed ID: 31703694
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Restoring the epigenetically silenced PCK2 suppresses renal cell carcinoma progression and increases sensitivity to sunitinib by promoting endoplasmic reticulum stress.
    Xiong Z; Yuan C; Shi J; Xiong W; Huang Y; Xiao W; Yang H; Chen K; Zhang X
    Theranostics; 2020; 10(25):11444-11461. PubMed ID: 33052225
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.